Almirall is a global biopharmaceutical company focused on medical dermatology. Founded in 1944 and with headquarters in Barcelona (Spain), our purpose is at the core of our work: “Transform the patients’ world by helping them realize their hopes and dreams for a healthy life”. Through pharmaceutical innovation, investment in R&D and strong commitment to global healthcare partnerships, we develop and commercialize solutions with specific focus on dermatological diseases such as psoriasis, actinic keratosis, atopic dermatitis or acne. We care and listen to our patients’ needs. We find solutions for them. We aim to empower them. Almirall has 1 R&D center, 2 chemical plants and 2 pharmaceutical plants. Our more than 1,900 employees make it possible for our treatments to be available in over 100 countries across 5 continents, through our 15 global affiliates and via a strategic partnership network. Almirall is listed on the Spanish Stock Exchange (ticker: ALM).
解锁市场时间线与信号动态
最近 90 天内有 39 个信号。
该公司进入各个市场的顺序 — 从最早到最新
14 active postings
Facharztaußendienst Dermatologie (Biologika) (m/w/d), Region L1: Dresden, Cottbus, Görlitz, Wittenberg
注册以查看完整信号动态
Almirall 的国际扩张与竞争对手的对比情况
Almirall你条形图显示所对比公司之间的相对规模。
列5| 公司 | 市场 | 新市场 | 势头 | 活动 | 扩张评分 |
|---|---|---|---|---|---|
 Almirall你 | 3 | 0 | +38% | 38 | 30 |
Product Manager (m/w/d) Atopic Dermatitis (AD)
查看职位Hamburg, Hamburg, Germany · 3天前
MEDICAL AFFAIRS SENIOR MANAGER Temporary
查看职位Barcelona, Catalonia, Spain · 4天前
IT BUSINESS PROCESS MANAGER
查看职位Sant Andreu de la Barca, Catalonia, Spain · 6天前
At Almirall, our "Act4Impact" strategy is the blueprint that integrates five vital pillars into our daily operations. This framework ensures our growth in medical dermatology is as responsible as it is innovative. Our commitment to a positive legacy includes: - Planet: A science-led roadmap toward Net Zero emissions. -People: Fostering a diverse and inclusive culture where our teams lead with integrity. - Patients: Placing people living with skin conditions at the core of every decision. - Part ...
已结束For those living with chronic skin conditions, physical symptoms are only one part of the journey. Psychological distress, social isolation, and sleep disturbances can persist even after skin clearance. At Almirall, we aim to lead a paradigm shift. By integrating the WHO-5 Well-being Index into our clinical trials, we demonstrate our commitment to placing patient wellbeing at the heart of everything we do. Our goal is to transform the patient's world - addressing the person that lives behind the ...
已结束For those living with chronic skin conditions, physical symptoms are only one part of the journey. Psychological distress, social isolation, and sleep disturbances can persist even after skin clearance. At Almirall, we aim to lead a paradigm shift. By integrating the WHO-5 Well-being Index into our clinical trials, we demonstrate our commitment to placing patient wellbeing at the heart of everything we do. Our goal is to transform the patient's world - addressing the person that lives behind the ...
已结束Almirall 股东重选 Carlos Gallardo 为首席执行官，Enrique de Leyva 为副总裁。公司将派发每股 0.19 欧元的灵活股息。
Qualifyze推出质量洞察平台，这是一个基于全球最大审计数据库的人工智能驱动工具，用于制药风险管理。
解锁已验证邮箱与直拨电话
免费 · 无需信用卡
关于 Almirall 的业务、市场和增长信号的快速解答。
